The Gavi Leap

The Gavi Leap

Transforming the Vaccine Alliance for the future through simplicity, transparency and synergy.

The Gavi Leap

Our vaccine portfolio

Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.

We strengthen health systems

Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.

Gavi funding for civil society organisations

A funding mechanism providing grants for CSOs working to reach zero-dose children and missed communities.

Market shaping

Working to improve the health of markets for vaccines and other immunisation products.

Our impact

Since its creation in 2000, Gavi has helped vaccinate over 1 billion children in the world’s poorest countries, preventing more than 17.3 million future deaths. Learn about how we've performed against our strategic goals, the independent…

Phase 6 (2026–2030)

In June 2024, the Board approved Gavi’s new five-year strategy, ‘Gavi 6.0’. Gavi 6.0 sets out the Alliance’s vision, mission, strategic goals, objectives, operating principles and critical enablers for Gavi’s sixth strategic period (2026–2030).…

Last updated: 12 Feb 2026